Home > Publications database > Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity. > print

001     144877
005     20240229112641.0
024 7 _ |a 10.3324/haematol.2018.203067
|2 doi
024 7 _ |a pmid:30792207
|2 pmid
024 7 _ |a pmc:PMC6717593
|2 pmc
024 7 _ |a 0390-6078
|2 ISSN
024 7 _ |a 1592-8721
|2 ISSN
024 7 _ |a altmetric:70443862
|2 altmetric
037 _ _ |a DKFZ-2019-02301
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Lu, Junyan
|b 0
245 _ _ |a Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity.
260 _ _ |a Pavia
|c 2019
|b Ferrata Storti Foundation64433
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1569319045_31252
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity.
536 _ _ |a 319H - Addenda (POF3-319H)
|0 G:(DE-HGF)POF3-319H
|c POF3-319H
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Böttcher, Martin
|b 1
700 1 _ |a Walther, Tatjana
|0 P:(DE-He78)e8feda17d03b95bda3e8717e79dc07b8
|b 2
|u dkfz
700 1 _ |a Mougiakakos, Dimitrios
|b 3
700 1 _ |a Zenz, Thorsten
|0 P:(DE-He78)f3d5f16b49eb47520def635be98d5576
|b 4
|u dkfz
700 1 _ |a Huber, Wolfgang
|b 5
773 _ _ |a 10.3324/haematol.2018.203067
|g Vol. 104, no. 9, p. 1830 - 1840
|0 PERI:(DE-600)2805244-4
|n 9
|p 1830 - 1840
|t Haematologica
|v 104
|y 2019
|x 1592-8721
909 C O |o oai:inrepo02.dkfz.de:144877
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)e8feda17d03b95bda3e8717e79dc07b8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)f3d5f16b49eb47520def635be98d5576
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-319H
|2 G:(DE-HGF)POF3-300
|v Addenda
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
920 1 _ |0 I:(DE-He78)G250-20160331
|k G250
|l Molekulare Therapie in der Hämatologie und Onkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G250-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21